109035 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; Processes for the isolation, preparation or purification of DNA or RNA; Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS
#2BIOLOGICALLY SELECTED NUCLEIC ACID ARTIFICIAL MINI-PROTEOME LIBRARIES
#3PROTEIN LIBRARY DISPLAY SYSTEMS AND METHODS THEREOF
#4INSTRUMENT AND METHODS INVOLVING HIGH-THROUGHPUT SCREENING AND DIRECTED EVOLUTION OF MOLECULAR FUNCTIONS
#5MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128
#6NUCLEIC ACID-TAGGED COMPOSITIONS AND METHODS FOR MULTIPLEXED PROTEIN-PROTEIN INTERACTION PROFILING
#7PLATFORM FOR DISCOVERY AND ANALYSIS OF THERAPEUTIC AGENTS
#8DISCOVERY OF A NEW INHIBITOR FOR THE YTH DOMAIN-CONTAINING M6A RNA READERS
#9COMPOSITIONS AND METHODS FOR ISOLATION OF RIBOSOME PROTECTED MESSENGER RNA (mRNA) FOOTPRINTS OR FRAGMENTS AND KITS THEREOF
#10PROTEINACEOUS MOLECULES AND USES THEREFOR
#11MATERIALS AND METHODS TO COMPREHENSIVELY DEFINE ADAPTIVE IMMUNE RESPONSES
#12GENERATING RECOMBINANT AFFINITY REAGENTS WITH ARRAYED TARGETS
#13METHODS, SYSTEMS, AND COMPOSITIONS OF GENERATING AND ANALYZING POLYPEPTIDE LIBRARIES
#14mRNA display antibody library and methods
#15tRNA, AMINOACYL tRNA, REAGENT FOR POLYPEPTIDE SYNTHESIS, INTRODUCTION METHOD OF UNNATURAL AMINO ACID, PRODUCTION METHOD OF POLYPEPTIDE, PRODUCTION METHOD OF NUCLEIC ACID DISPLAY LIBRARY, NUCLEIC ACID-POLYPEPTIDE CONJUGATE, AND SCREENING METHOD
#16mRNA display antibody library and methods
#17ANALYZING EXPRESSION OF PROTEIN-CODING VARIANTS IN CELLS
#18ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
#19Single-Molecule Phenotype Analysis
#20METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES
#21MODULAR TARGETED THERAPEUTIC AGENTS AND METHODS OF MAKING SAME
#22Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling
#23PLATFORM FOR DISCOVERY AND ANALYSIS OF THERAPEUTIC AGENTS
#24NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#25NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#26Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#27NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#28METHODS AND COMPOSITIONS FOR IDENTIFYING TRAITS USING A CELL-FREE SYSTEM
#29NUCLEIC ACID ARTIFICIAL MINI-PROTEOME LIBRARIES
#30TRANSMEMBRANE SERINE PROTEASE 2 (TMPRSS2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#31METHODS AND COMPOSITIONS FOR MAKING AND USING PEPTIDE ARRAYS
#32NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#33FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
#34NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#35Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#36METHODS AND USE OF CHIMERIC PROTEINS
#37IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING
#38In immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#39NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#40NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#41Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#42PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#43NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#44METHOD FOR PRODUCING PEPTIDE CONTAINING NON-NATURAL AMINO ACID
#45NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#46NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#47NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#48NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#49Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#50NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#51NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#52METHOD FOR PRODUCING NON-RIBOSOMAL RNA-CONTAINING SAMPLE
#53PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#54Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#55TRANSGENIC BACTERIA AND METHODS OF USING SAME
#56Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#57NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#58Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#59Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#60ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS
#61FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
#62Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#63Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#64PEPTIDE CONSTRUCTS AND ASSAY SYSTEMS
#65Methods and compositions for identifying neoantigens for use in treating cancer
#66Methods and compositions for identifying neoantigens for use in treating and preventing cancer
#67Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#68ASSEMBLY OF PROTEIN COMPLEXES ON A CHIP
#69Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#70Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#71Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#72Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#73Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#74Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#75Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#76Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#77Multivalent glycopeptides that tightly bind to carbohydrate-binding monoclonal antibody family PGT128
#78DEVICES AND METHODS FOR DISPLAY OF ENCODED PEPTIDES, POLYPEPTIDES, AND PROTEINS ON DNA
#79Single cell bar-coding for antibody discovery
#80Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#81Methods of Selecting and Detecting Binding Peptides
#82TCR libraries
#83Generating recombinant affinity reagents with arrayed targets
#84Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#85Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#86Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#87Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#88Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#89GM-CSF and IL-4 Conjugates, Compositions, and Methods Related Thereto
#90mRNA display antibody library and methods
#91Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#92MRNA display antibody library and methods
#93METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES
#94Antigen binding molecules and methods of use thereof
#95High-speed in vitro screening method
#96Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#97Fibronectin binding domains with reduced immunogenicity
#98Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#99Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#100Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#101Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#102Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling
#103Modification of D- and T-arms of tRNA enhancing D-amino acid and β-amino acid uptake
#104Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#105Method for producing complex of RNA molecule and peptide, and utilization thereof
#106Rapid display method in translational synthesis of peptide
#107X-display complexes for protein screening methods
#108Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#109Multivalent glycopeptides that tightly bind to target proteins
#110Fibronectin binding domains with reduced immunogenicity
#111Directed evolution of multivalent glycopeptides that tightly bind to target proteins
#112AN ENGINEERED MULTI-COMPONENT SYSTEM FOR IDENTIFICATION AND CHARACTERISATION OF T-CELL RECEPTORS, T-CELL ANTIGENS AND THEIR FUNCTIONAL INTERACTION
#113Mapping protein binding sites and conformational epitopes using cysteine labelling and surface display library
#114Single cell bar-coding for antibody discovery
#115Devices and methods for display of encoded peptides, PolyPeptides, and proteins on DNA
#116Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#117METHODS OF SCREENING, SELECTING, AND IDENTIFYING CYTOTOXIC RECOMBINANT POLYPEPTIDES BASED ON AN INTERIM DIMINUTION OF RIBOTOXICITY
#118Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#119BETA-CATENIN BARCODED PEPTIDES
#120Single cell bar-coding for antibody discovery
#121mRNA display antibody library and methods
#122Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#123Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#124Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#125Method of discovering specific functional antibodies
#126Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#127Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#128Modular targeted therapeutic agents and methods of making same
#129Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
#130MRNA display antibody library and methods
#131Platform for discovery and analysis of therapeutic agents
#132NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#133Antigen binding molecules and methods of use thereof
#134NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#135Generating recombinant affinity reagents with arrayed targets
#136TCR libraries
#137GM-CSF and IL-4 conjugates, compositions, and methods related thereto
#138Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#139GENERATION OF LIBRARY OF SOLUBLE RANDOM POLYPEPTIDES LINKED TO mRNA
#140Peptide constructs and assay systems
#141METHODS FOR PREPARING HIGH THROUGHPUT PEPTIDOMIMETICS, ORALLY BIOAVAILABLE DRUGS AND COMPOSITIONS CONTAINING SAME
#142Encoded self-assembling chemical libraries (ESACHEL)
#143DNA DISPLAY AND METHODS THEREOF
#144Methods for obtaining information from single cells within populations using DNA origami nanostructures without the need for single cell sorting
#145Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling
#146Libraries of modified fibronectin type III tenth domain-containing polypeptides
#147Methods of single-cell barcoding and sequencing
#148BROAD-SPECTRUM SEROLOGICAL DIAGNOSTICS AND USES THEREOF
#149METHODS AND SYSTEMS FOR BARCODING NUCLEIC ACID MOLECULES FROM INDIVIDUAL CELLS OR CELL POPULATIONS
#150Protein screening methods
#151POLYNUCLEOTIDE CONSTRUCT CAPABLE OF DISPLAYING FAB IN A CELL-FREE TRANSLATION SYSTEM, AND METHOD FOR MANUFACTURING AND SCREENING FAB USING SAME
#152Presentation of bioactive proteins
#153Single-molecule phenotype analysis
#154Peptide with safer secondary structure, peptide library, and production methods for same
#155Protein and peptide libraries
#156Methods of treating cancer by administering IGF-IR binding molecules
#157BARCODED PEPTIDES
#158Method for producing peptides having azole-derived skeleton
#159Fibronectin binding domains with reduced immunogenicity
#160Methods and compositions for controlling gene expression and treating cancer
#161Rapid Affinity Measurement of Peptide Ligands and Reagents Therefor
#162Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
#163Fibronectin binding domains with reduced immunogenicity
#164Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
#165FUNCTIONALIZED POLYPEPTIDES
#166COW ANTIBODY SCAFFOLD POLYPEPTIDE METHOD AND COMPOSITION
#167Directed evolution of multivalent glycopeptides that tightly bind to target proteins
#168Multivalent glycopeptides that tightly bind to target proteins
#169Production method for charged non-protein amino acid-containing peptide
#170Method for producing peptide library, peptide library, and screening method
#171HIGH AFFINITY ADAPTOR MOLECULES FOR REDIRECTING ANTIBODY SPECIFITY
#172High throughput generation and affinity maturation of humanized antibody
#173METHOD FOR GENERATING ULTRA HIGH AFFINITY PEPTIDE LIGANDS
#174Efficient method for displaying protein multimer
#175Methods for obtaining information from single cells within populations using DNA origami nanostructures without the need for single cell sorting
#176Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling
#177Devices and methods for display of encoded peptides, polypeptides, and proteins on DNA
#178Nucleic acid linker
#179FLEXIBLE DISPLAY METHOD
#180Protein screening methods
#181Single cell bar-coding for antibody discovery
#182Generation of library of soluble random polypeptides linked to mRNA
#183PEPTIDES FOR THE BINDING OF NUCLEOTIDE TARGETS
#184Polyamide compound and pharmaceutical composition for treating mitochondrial genetic disease
#185Methods and compositions
#186Fibronectin binding domains with reduced immunogenicity
#187Ligand having three finger structure and a method for detecting a molecule by using thereof
#188Single cell bar-coding for antibody discovery
#189Protein-immobilizing solid phase, polynucleotide-immobilizing solid phase, and nucleic acid recovery method
#190Method for detecting protein that interacts with target substance
#191Protein and peptide libraries
#192Connector compound peptide phage display
#193Functionalized polypeptides
#194Azoline compound and azole compound library and method for producing same
#195Peptide constructs and assay systems
#196Peptide library production method, peptide library, and screening method
#197Peptide with safer secondary structure, peptide library, and production methods for same
#198Efficient method for displaying protein multimer
#199Polynucleotide construct capable of displaying fab in a cell-free translation system, and method for manufacturing and screening fab using same
#200Fibronectin binding domains with reduced immunogenicity
#201Methods to Identify Synthetic and Natural RNA Elements that Enhance Protein Translation
#202Fibronectin binding domains with reduced immunogenicity
#203Constitution of tool for analyzing biomolecular interaction and analysis method using same
#204In vitro sorting method
#205Modular targeted therapeutic agents and methods of making same
#206Method for constructing libraries of non-standard peptide compounds comprising N-methyl amino acids and other special (non-standard) amino acids and method for searching and identifying active species
#207Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides
#208High affinity adaptor molecules for redirecting antibody specifity
#209PEPTIDE DISPLAY ARRAYS
#210PEPTIDE CONSTRUCTS AND ASSAY SYSTEMS
#211RAPID DISPLAY METHOD IN TRANSLATIONAL SYNTHESIS OF PEPTIDE
#212Encoded self-assembling chemical libraries (ESACHEL)
#213METHODS FOR MAKING HIV VACCINES AND RELATED COMPOSITIONS
#214Functionalized polypeptides
#215Protein screening methods
#216Methods and compositions
#217Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors
#218Encoded self-assembling chemical libraries (ESACHEL)
#219Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
#220Generation of library of soluble random polypeptides linked to mRNA
#221Optical sorting method
#222Methods for enriching subpopulations
#223Polymer evolution via templated synthesis
#224Optical sorting method
#225Linker for constructing mRNA-puromycin-protein conjugate
#226Selection of proteins using RNA-protein fusions
#227DNA-protein fusions and uses thereof
#228Ribosome Display or Mrna Display Method With Selection for Increased Stability of the Protein
#229In vitro sorting method
#230Pharmacokinetic modulation and compositions for modified FN3 polypeptides
#231Inhibitors of type 2 vascular endothelial growth factor receptors
#232In vitro sorting method
#233System and methods for nucleic acid and polypeptide selection
#234Peptide acceptor ligation methods
#235High throughput generation and affinity maturation of humanized antibody
#236Methods and means relating to protein variants
#237Encoded self-assembling chemical libraries (esachel)
#238Methods for screening polypeptides
#239Nucleic-acid programmable protein arrays
#240Method for forming a stable complex comprising a transcription product and translation product of a dna encoding a desired polypeptide, a nucleic acid construct used for the method, a complex formed by the method, and screening of a functional protein and mrna or dna encoding the protein using the method
#241Combinatorial enzymatic complexes
#242Optical sorting method
#243Methods of synthesizing polynucleotide via reverse translation from protein and oligonucleotide used in this method
#244Compositions and methods for the identification and selection of nucleic acids and polypeptides
#245In Vitro sorting method
#246In vitro sorting method
#247Optical sorting method
#248Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers